Joel Greenblatt · Magic Formula : forte rentabilité du capital à un EV/EBIT bas
Is Apellis Pharmaceuticals, Inc. (APLS) a Joel Greenblatt Stock?
Partial match: either cheap or high-quality, but not both.
59/100
Mitigé
1/5 critères validés
Les critères de Joel Greenblatt, appliqués à APLS
EBIT/EV yield ≥ 10%
clé1.0%
ROIC ≥ 25%
clé18.1%
EV/EBIT ≤ 12
96.0x
Gross margin ≥ 30%
90.1%
Comment APLS se classe selon d'autres stratégies
Données financières en direct
Cap. boursière
$5.25B
PER (TTM)
38.8x
ROIC (TTM)
18.11%
Marge brute
90.12%
Autres analyses Joel Greenblatt
Questions fréquentes
What is APLS's Joel Greenblatt fit score?
APLS scores 59/100 on our Joel Greenblatt fit engine. Partial match: either cheap or high-quality, but not both.
Does Joel Greenblatt actually own APLS?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends APLS.
How often is this score updated?
APLS's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Outil éducatif, pas un conseil en investissement. Les scores sont calculés à partir de données financières publiques selon les critères publiés de chaque stratégie d'investissement. Nous ne prétendons pas que Joel Greenblatt possède ou recommande APLS personnellement.
